l

The content of this website is intended for healthcare professionals only

Also in the press

US government gives GSK up to $200 million for antibiotic research

Thursday, 23 May 2013

US GOVERNMENT GIVES GSK UP TO $200 MILLION FOR ANTIBIOTIC RESEARCH

The US government is to give GlaxoSmithKline up to $200 million over the next five years to help fund research into new antibiotics, reports The Wall Street Journal (p11).

According to the WSJ, the US government is concerned about the rise of antibiotic-resistant bacteria and are particularly eager to have new antibiotics in hand to fight any lethal microbes that could be deployed in a bioterrorist attack.

Under the deal, GSK, which unlike many other drug companies still has an antibiotic research group, will receive an initial $40 million over 18 months from the Biomedical Advanced Research and Development Authority (Barda).

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470